Evidence map›Paper›PMID 33934950›Full record

ArticleThe Journal of arthroplasty2021

Competing Risk Analysis: What Does It Mean and When Do We Need It in Orthopedics Research?

Hilal Maradit Kremers, Katrina L Devick, Dirk R Larson, David G Lewallen, Daniel J Berry, Cynthia S Crowson

Abstract read
In one paragraph

Article in The Journal of arthroplasty, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Muscle Strength in ICU Patients Measured by Handgrip Dynamometer and ICU-Acquired Weakness: A Prospective, Single-Center Observational Study.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Observational
  10. Article
  11. Article
  12. Article
  13. Survival analyses and their applications in orthopaedics.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023
    Review
  14. Article
  15. Living With Survival Analysis in Orthopedics.The Journal of arthroplasty · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Hilal Maradit KremersDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN.
Katrina L DevickDepartment of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ.
Dirk R LarsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
David G LewallenDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN.
Daniel J BerryDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN.
Cynthia S CrowsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN; Division of Rheumatology, Mayo Clinic, Rochester, MN.

Funding

Resource CoreP30AR076312 · NIAMS · MAYO CLINIC ROCHESTER · PI Daniel Berry · 2019 to 2026
$5.5M
NIAMS NIH HHS P30 AR076312
6 · The paper itself

Abstract

Most orthopedic studies involve survival analysis examining the time to an event of interest, such as a specific complication or revision surgery. Competing risks commonly arise in such studies when patients are at risk of more than one mutually exclusive event, such as death, or when the rate of an event depends on the rates of other competing events. In this article, we briefly describe the survival analysis censoring methodology, common fatal and nonfatal competing events, and define circumstances where standard survival analysis can fail in the setting of competing risks with real-world examples from orthopedics. Please visit the followinghttps://youtu.be/ifj_Mm3eGu8for a video that explains the highlights of the paper in practical terms.

Indexed as

Orthopedic ProceduresOrthopedicsHumansReoperationRiskRisk AssessmentSurvival Analysisbiascensoringcompeting risksurvival analysistotal joint arthroplasty

Identifiers

PMID33934950
PMCPMC8478701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.